Inflammatory bowel disease, known as Crohn's disease and ulcerative colitis, is an unexplained disease characterized by chronic inflammation that repeats a cycle of relapse, improvement, and complications. The cause of inflammatory bowel disease is not clearly known, but it is predicted that a complex of various factors precipitate its occurrence. In particular, inflammatory mediators, such as cytokine, induce an increase in cell-mediated inflammatory responses. Focal tissue damage then occurs in the intestinal mucosa because of the weakening of the immune-modulating functions of cotton. Immune and inflammatory responses do not decrease appropriately but continue until they lead to chronic inflammation. Current research has focused on the cytokine genes, which have important roles in these inflammatory responses. Cytokine is a glycoprotein that is produced mostly in activated immune cells. It connects the activation, multiplication, and differentiation between immune cells, which causes focal tissue damage and inflammatory response. Moreover, butyrate, which originates in dietary fiber and plays an important role in the structure and function of the intestinal area, shows control functions in the intestinal immune system by decreasing the proinflammatory cytokine and increasing the anti-inflammatory cytokine. Therefore, this research investigated the molecular mechanism of the anti-inflammatory effects of butyrate to comprehend the cytokine controlling abilities of butyrate in the immune cells. Butyrate is expected to have potential in new treatment strategies for inflammatory bowel disease.
how eating habit is related to disease occurrence [46] .
Particularly, in terms of bacterial infection and relevance to cleanliness, it has been proven that inflammatory bowel disease is prevented when the level of cleanliness is not high [43] . The attack rate of inflammatory bowel disease is high amongst family members. When there is a patient with the Crohn's disease or ulcerative colitis within the family, the risk of occurrence in Crohn's disease in line family members accounts for 10~25%. Additionally, the prevalence rate is higher in biovular twins rather than uniovular twins, and as difference is shown in the prevalence rate amongst diverse racial groups, it provides support for the possibility for genetic factors [9, 14, 77] .
Microbiological factor
The formational changes in the intestinal microorganisms can be identified as the representative example of microbiological factors [33] . Meanwhile, changes are happening in the formation of intestinal microorganisms and there is an increase in the number of germs in the inflammatory bowel disease [40] . Therefore, a theory is being suggested on how the incorrect immune reactions about intestinal microorganisms will set the foundation for the occurrence of inflammatory bowel disease ( Fig. 2) [19, 30, 33] . The IEC barrier formed of intestinal epithelial cells (IECs) protects the lamina muscularis mucosae from intestinal microorganisms existing within the intestine. In a healthy entity, nonpathogenic commensal is enabled to live within the intestine without encountering harmful immunoreactions. In other words, it exists in the state of immune tolerance. However, in terms of an entity which holds genetic sensitivity, the intestinal functions are not able to operate properly, leading to the invasion of commensal within the internal part of the mucous membrane. The intrusive microorganism applies the PRRs (pattern recognition receptors) like TLR (toll-like receptor) and NLR (nucleotide-binding oligomrization domain (Nod)-like receptor) to response with immunocytes such as the macrophage, dentritic cell, and the neutrophil. The activation of PRR promotes the expression of proinflammatory mediators such as cytokine, chemokine, and prostaglandin and accelerates the immune reaction. As a result, it leads to the occurrence of inflammatory bowel disease [31, 83] .
Immunological factor
Regardless of the cause of the occurrence, a series of processes in the inflammatory cell response due to inflammation mediator like cytokine becomes induced or amplified, or the weakening of the immunity control function leads to inducing the partial tissue damage in the intestinal mucosa [34, 67, 68] . Thus, in terms of acute inflammatory response, quick recovery generally takes due to being limited and temporary following the defense mechanism of normal hosts. However, Fig. 2 . Simple model for the relationship between enteric microbiota and mucosal immune reactions. DC, dendritic cells [33] .
in the chronic inflammatory bowel disease, immunity and inflammation response do not become decreased appropriately, but continues and leads to becoming a chronic inflammation [48] . Therefore, amongst the fields of studies on inflammatory bowel disease, interest is being concentrated to factors that sustain the mediator and cellular immune response which induce the movement of neutrophil and mononuclear cell that intervene in the acute and chronic inflammatory responses.
Cytokine
Currently, interests are being concentrated to cytokine genes which are responsible for important roles in these inflammatory responses. Cytokine is the glucoprotein which mainly produce the activated immunocyte and the molecular weight is about 8~19 kD, and during immune response, it brings up partial tissue damage and inflammatory responses by relating to activation, proliferation, and division between immunocytes such as T cell, B cell, and macrophagocyte [29] . The major cells that form the cell-mediated immune system are the macrophage and T lymph cells, and macrophage produces cytokine like interleukin-1 (IL-1), IL-6, IL-8, tumor necrosis factor-alpha (TNF-α). Lymph cells are divided into CD4-T cell and CD8-T cell according to the surface antigen. CD4-T cell is distinguished into T helper (Th)1 cell and Th2 cell due to the produced cytokine, and Th1 cell mainly secretes IL-2, tumor necrosis factor-beta (TNF-β), interferon-gamma (IFN-γ) and assists in the division of cytotoxic T lymph cells. It also becomes involved in the natural form of immune response. Th2 cell secretes IL-4, IL-5, IL-6, IL-10, IL-13 and helps in the application of B lymphocyte and becomes involved in the antibody formation as well as taking the role in eliminating the external antigen [35, 50] .
Moreover, the Th2 cell suppresses other cytokine through further IL-20 and takes the important role in controlling the strength of immune response. Inflammatory bowel disease sets the imbalance of immune response in Th1 and Th2 as the characteristic [4, 81] , and this brings about a incongruity between the proinflammatory cytokine and anti-inflammatory cytokine and is known to play an important role in the chronicization, relapse, and practice of diseases [45, 62] . The cytokine system is being controlled through extremely complex stages, and many parts bring about cross-reaction. Since it takes part in complex interaction instead of uniform stimulation and suppression, the amount of accumulated knowledge is not as much compared to its importance [28] .
Proinflammatory cytokine
Proinflammatory cytokine include the TNF-α, IL-1α and the IL-6. These control the expressions of genes involved in the cell receptor and growth components, and contains the functions which induce the cell growth and differentiation, and not only are they relevant to immune system cells, but are also secreted from various forms of tumor cell line including the keratinocyte and fibroblast, and are applied in cells through the form of autocrine and lateral secretion [5, 18] . Additionally, they are known to increase the formation of vascularization by applying with other growth factors [39] .
IL-1 is the representative cytokine which induces inflammatory response, and the expression is controlled through the NF-κB. Furthermore, IL-1 itself is also the strong factor which can activate the NF-κB. Therefore, IL-1 eventually increases the activation of NF-κB, and the expression of various proinflammatory mediators controlled by this factor and leads to inducement in excessive inflammatory response [21, 76] . As a proof supportive of this fact, the severity of inflammatory bowel disease is not only proportional to the expression degree of IL-1 [12] , but the report which claims that the symptoms can be eased through the suppress of IL-1 can be stated as a form of evidence [73] .
Since IL-2 is capable of maintaining the growth of T lymphocyte, which displays the cytotoxicity, for a considerable amount of period, it was referred to as the T cell growth (TCGF) existing in the culture medium of lymphocyte. From then on, IL-2 created through recombinants was applied as it was identified that activation of T cell as well as natural killer cell, NK cell, lymphocyte-activated killer (LAK) cell, B cell growth factor, and the stimulating factor of monocyte lineage cells were evident [35] .
TNF-α is a proinflammatory cytokine which is in charge of important roles in the expression and control of immune responses [36] . It gives signal to the tumor cell and causes it to kill itself, or even hiders the reproduction within the virus cells. It is the signal molecule which becomes widely involved in innate immune response as it stimulates macrophage and promotes inflammatory response. This TNF-α is known to be involved in the occurrence of Alzheimer, cancer, and depression besides the inflammatory bowel disease [9] . Inflammatory bowel disease is closely related to the secretion of TNF-α, and its production was increased in the mucous membrane of patients diagnosed with the Crohn's disease [9, 36] . When the disease first begins, TNF-α becomes produced first, and as the IL-1β increases, they stimulate each other and lead to the increase in the IL-6 [6, 69] . TNF-α includes antigen invasion in the epithelial cell of the small intestine in patients diagnosed with the Crohn's disease and induces Th1 cytokine during the start and progress of the disease [9, 74] . Monoclonal antibodies regarding TNF-α suppresses the production of TNF-α and IFN-γ in the mononuclear cell and reduces the intestinal inflammation, and is being applied as the treatment of Crohn's disease [75] .
IFN-γ is the type II interferon, which is a type of interferon unstable in the acid, and is distinguished from the I type interferon, which is stabilized in the acid, and type I interfer- an anti-inflammatory application and is an essential factor in the immune regulation of the gastrointestinal area [35, 44, 55] . It is known to relatively decrease in the active inflammatory bowel disease and control the intestinal inflammation in the animal model [23, 57] . Additionally, according to recent researches, results have claimed that recovery was displayed in clinical symptoms and endoscopic improvement when IL-10 is dosed into patients with active
Crohn's disease [16, 71, 79] . [26, 65] , and the pathophysiology of inflammatory bowel disease is expanding its concept from its previous Th1. Th2 cytokine unbalance into the unbalance of Th1/Th17/Treg cell [24, 59] . Th17 cell includes the IL-17, the representative cytokine, and expresses the IL-17F, IL-21 and IL-22 and gives influence to the occurrence of various immune diseases such as rheumatoid arthritis, autoimmune encephalomyelitis, and the Crohn's disease. In particular, it is claimed to be important in the occurrence of inflammatory bowel disease, but the regulatory mechanism of inflammation is not clear [22] .
However, as IL-17 becomes overly expressed in the tissue with chronic inflammation, the differentiation of Th17 cell becomes displayed as high. This is not only observed in chronic systematic inflammation, but is also found in multiple intestinal inflammatory diseases including the inflammatory bowel disease [49] . mor necrosis factor (TNF) called the monoclonal antibodies [11] . However, these medicines are currently frequently bringing about severe side effects. There are also problems identified with the treatment. In terms of the commonly applied corticosteroids, it is known to be very effective in suppressing almost all proinflammatory cytokine and causing improvements in the symptoms. Thus, it is very difficult or even possible to increase the amount of dosed medicine or refrain from usage. In these cases, the symptom commonly relapses during the early stage, and for the Crohn's disease, it has been identified that patients show dependence on steroids. However, as it is well known, there is a limit to application of steroids due to numerous side effects resulting after high amounts of intake over a long period of time.
Furthermore, in terms of immunosuppressant, there is a limit to application due to side effects such as bone marrow suppression or pancreatitis [38] . In cases when cytokine are directly applied, it leads to low bioavailability due to the injection of protein, and it may lead to occurrence of problems such as low pharmacokinetic and chemical instability as well as inducement of immune response [45] . Currently, as active researches are taking place about etiology of inflammatory bowel disease, cytokine and cells related to the Crohn's disease and ulcerative colitis are being identified continually, and numerous biological medicine which selectively attacks specific molecules or routes related to the intestinal inflammation have been developed [64, 66] . Accordingly, necessity in the cytokine gene therapy is being suggested for inflammatory bowel disease, and attention is being focused in the application [45] . Therefore, researches on inflammatory mediators and cytokine amongst pathophysiology are needed in order to gain a deeper understanding about chronic inflammatory bowel disease and develop new treatment methods.
Effects of Butyrate for inflammatory bowel disease
Butyrate are mostly short-chained fatty acids which holds 4 carbons created when the carbohydrate of food within the colonic mucosa becomes digested due to bacteria [14, 70] .
Butyrate is the primary source of energy of the colonic epithelial cells, and about 70% amongst the total energy consumption relies on butyrate. Additionally, the luminal concentration of butyrate can be 30 mM [10, 37, 60, 61] . As butyrate controlled the balance between the epithelial cell proliferation, differentiation, and apoptosis, it maintains the health and integrity of the intestinal area, and plays an important part for anti-cancer, anti-inflammation, and oxidative stress conditions [14, 20, 70] . Moreover, butyrate enema or high-fiber dietary increase the density of butyrate within the colon and showed outstanding effects in the inflammation treatment within the colonic mucosa [63] . For these reasons, butyrate is receiving focus as the remedy which shows possibility in treatment for the inflammatory bowel disease.
In this study, molecular mechanism about the anti-inflammatory effects of butyrate is to be comprehended through the cytokine control functions possessed by the butyrate in the immunocyte. Butyrate suppresses the LPS-and cytokine-stimulated production of proinflammatory mediators including TNF-α, IL-6. Butyrate also enhances the release of the anti-inflammatory cytokine IL-10 (Table 1) [82] .
Researches on anti-inflammatory effects of butyrate which applies animal and human cells in vitro are being conducted actively. Jin-Sun Park and et., conducted the effects of butyrate in the production of proinflammatory and anti-inflammatory cytokine in the murin macrophage RAW 264.7
cells. As a result of observing the TNF-α, IL-6 and IL-10 mRNA levels by processing the sodium butyrate for 6 hours after stimulating the RAW 264.7 cells by the IFN-γ, TNF-α and IL-6 mRNA levels decreased due to the butyrate, but IL-10 mRNA levels displayed an increase. Due to these results, it can be identified that the sodium butyrate can control the cytokine expression in the transcription level (Fig.  5 ) [54] .
Moreover, butyrate shows anti-inflammatory effects by suppressing the IL-12 and TNF-α in the human monocytes and increasing the IL-10 production. As it is displayed in mRNA levels became controlled. As a result, it was identified that the IL-12 production was controlled as the butyrate suppressed the genetic transcription, which became involved with the IL-12 production (Fig. 7) . The effects of butyrate caused on the cytokine production of human PBMC (peripheral blood mononuclear cell) was observed as well.
Th1-associated cytokines IL-2 and IFN-γ became down regulated due to the butyrate (Fig. 8B) , and in contrast, Th2-related cytokines IL-4 and IL-10 became up regulated in a concentration-dependent manner (Fig. 8C ) [63] . Lu Liu and et., observed the effects of butyrate for cytokine secretion when LPS (1 mg/l) and butyrate (1 mmol/l)
were stimulated for 24 hours in the human dendritic cell.
IL-12p40 secretion caused by the LPS stimulation decreased by about 3 times due to the butyrate, and IFN-γ secretion decreased by about 5 times. In contrast, IL-10 secretion increased by about 7.5~11 times due to the butyrate (Fig. 9) [47]. In order to bring about more in-depth results based on the research results mentioned above, in vivo researches are being conducted simultaneously. Cell-free supernatants were collected 24 h after addition of bacterial stimuli and analyzed by ELISA. Mean %control responses±SEM calculated from 3 to 9 independent experiments are shown. In unstimulated cultures cytokines were undetectable. Mean cytokine levels in the absence of butyrate were 1402±426 pg/ml (IL-12p40), 199±74 pg/ml (IL-12p70), 1190±307 pg/ml (TNF-α) and 1090±330 pg/ml (IL-10). *p<0.05 for given and all higher concentrations of butyrate [63] . Fig. 7 . RT-PCR analysis shows significantly reduced levels of mRNA for IL-12p40 and p35 in stimulated cells treated with butyrate. Human monocytes (1x10 6 cells/well) were cultured with medium alone, SAC (75 μg/ml) and IFN-γ (200 U/ml) with or without butyrate at the indicated concentrations. After a culture period of 18 h, cells were harvested and total RNA was prepared. Results are representative of three independent experiments using monocytes from three different donors [63] .
In the research conducted by Rodrigo Goulart Pacheco and et., effects caused by butyrate on the production of TNF-α, IL-1β, and TGF-β were examined through the application of colonic mucosa. Similarly as the humans' colitis, inflammation was created in rat, and butyrate was injected in the form of an enema after the enema surgery. Over the period of 8 weeks, it was inserted 2 times a week. Then, the amounts of TNF-α, IL-1β, and TGF-β were measured through ELISA in the attained colonic mucosa culture medium. The highest levels of TNF-α (Fig. 10A ), IL-1β (Fig.   10B ), and TGF-β (Fig. 10C) were observed in the colonic mucosa culture medium inserted with saline through a enema form, and in the group where the butyrate was processed, the amount of TNF-α, IL-1β, and TGF-β decreased significantly through a control level [53] .
According to the research conducted by J-P Segain and et., inflammatory mucosal tissues produced great amounts of TNF, IL-1α, IL-6 when compared to normal mucosal tissues (Fig. 11A) . When the butyrate is processed here, the TNF level decreased through a butyrate concentration-dependent manner in both inflammatory (p=0.0001) and non-inflammatory/normal mucosal tissues (p=0.0153). When the 10 mM butyrate is processed, the TNF levels return to the control level. The TNF production decreases significantly if the 2 mM butyrate is processed by stimulating the TNF production after processing the LPS in the PBMC of a patient diagnosed with the Crohn's disease and a normal healthy , PBMC (1x10 6 cells/well) were cultured for 24 h in the presence or absence of butyrate with anti-CD3 (1 μg/ml). Supernatants were then harvested and analyzed for cytokine production by ELISA. Mean %control responses±SEM were calculated from 4 to 12 independent experiments. In unstimulated cultures cytokine levels were undetectable. Mean cytokine levels in the absence of butyrate were 1544±674 pg/ml (IL-2), 2002±488 pg/ml (IFN-γ), 123±15 pg/ml (IL-4) and 2145±593 pg/ml (IL-10). *p<0.05 for given and all higher concentrations of butyrate [63] . Fig. 9 . Effects of butyrate on DCs cytokine release. Immature DCs were generated from monocytes in the absence or presence of 1 mmol/l butyrate and stimulated with LPS (1 mg/l) or butyrate (1 mmol/l) for 24 h. Then IL-12, IL-10, and IFN-γ were measured by ELISA using matched-pair antibodies. Wells from which IL-12 p40, IL-10, and IFN-γ were collected contained 1 ml culture medium with 1x10 6 DCs. Shown are the means±SD (n=5). *p<0.05 [47] . person (Fig. 11B) . Additionally, as a result of observing TNF-α, IL-1α, and IL-6 mRNA levels in the inflammatory mucosal tissues and LPMC through the RT-PCR, butyrate decreased the mRNA cytokine expression in a concentration-dependent manner (Fig. 12A) . Furthermore, in the PBMC, the effects of butyrate were identified through the expression of TNF-α, TNF-β, IL-1α, IL-6 mRNA through the inflammatory response induced by LPS. Likewise the previous result, butyrate decreased or suppressed the expression of cytokine mRNAs induced by LPS (Fig. 12B ) [72] .
Conclusion
Inflammatory bowel disease, which is characterized by A B Fig. 12 . Effect of butyrate on proinflammatory cytokine mRNA. Biopsies and isolated lamina propria mononuclear cells (LPMC) (A) from inflamed mucosa of patients with Crohn's disease were cultured for 24 h with or without 2 or 10 mM butyrate. Peripheral blood mononuclear cells (PBMC) (B) were cultured for 24 h alone or in the presence of 2.5 μg/ml lipopolysaccharide (LPS) and then for another 20 h period under the same conditions with or without 2 mM butyrate. RNA was extracted and RT-PCR was performed using primers designed for interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF)-β, TNF-α, and control β-actin [72] .
chronic inflammation that repeats in relapse and improvement and other complications, has not been accurately known for its occurrence factors. However, it is perceived that various factors are in relevance, and according to previous researches, genetic and immunological conditions are being recognized as one of the important factors. Currently, researches on the correlation between cytokine genes and inflammatory bowel disease are being progressed actively, and as numerous biological medications have been developed in which they selectively attack specific molecules or routes related to intestinal inflammation, the necessity of cytokine gene therapy in treatment of inflammatory bowel disease is being suggested.
Butyrate originates from dietary fiber, which is an im-portant substrate in the structure and functions of the intestine. As it decreases the amount of proinflammatory cytokine and increases anti-inflammatory cytokine, it shows controlling functions regarding the intestinal immune system.
From here on, it is perceived that the complicated roles of cytokine involved in the occurrence and progress of inflammatory bowel disease as well as the effects caused by butyrate on the production of cytokine will be identified gradually. If more resources on butyrate become accumulated, new treatment strategies will be suggested for the inflammatory bowel disease.
